Crossmark

CCL19 and CCR6 as diagnostic biomarkers for differentiating phyllodes tumors from breast fibroadenomas: a machine learning-driven approach integrating EMT biology

Crossref DOI link: https://doi.org/10.1007/s12672-026-04451-0

Published Online: 2026-02-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gao, Hui

Lan, YanDan

Lv, LiQiong

Liu, Hui
Funding

Funding for this research was provided by:

Guangxi Health Commission (Z-A20230938)

Guangxi Health Commission (Z-A20230938)

Guangxi Health Commission (Z-A20230938)

Guangxi Health Commission (Z-A20230938)
License Information

Text and Data Mining valid from 2026-02-05

Version of Record valid from 2026-03-09
More Information

Article History

Received: 18 August 2025

Accepted: 13 January 2026

First Online: 5 February 2026

Declarations

:

: Ethical review and approval were waived for this study due to the data reproduced from Article utilized human tissue that was procured via our Pathology bank which provides de-identified samples. The Pathology Bank protocols are in accordance with the ethical standards of our institution and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below